DKSC (Dakshidin) Accounts Payable: $0.02 Mil (As of Sep. 2023)


What is Dakshidin Accounts Payable?

Dakshidin DKSC +33.33% Accounts Payable is $0.02 Mil as of Sep. 2023.

Dakshidin's Accounts Payable for the quarter that ended in Sep. 2023 was $0.02 Mil.

Dakshidin's quarterly Accounts Payable declined from Mar. 2020 ($0.13 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($0.02 Mil).

Dakshidin Accounts Payable Historical Data

* Premium members only.

The historical data trend for Dakshidin's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Accounts Payable Chart

Dakshidin Annual Data
Trend
Accounts Payable

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Accounts Payable 0.00 0.13 0.00 0.02

Dakshidin Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.02 Mil mean?
Dakshidin (DKSC) has a Accounts Payable of $0.02 Mil as of Sep. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Dakshidin and its competitors.
Is Dakshidin's Accounts Payable too high?
Dakshidin's current Accounts Payable is $0.02 Mil.
How does Dakshidin's Accounts Payable compare to ECEZ and AFBG?
Dakshidin's Accounts Payable of $0.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Dakshidin and its competitors. Dakshidin's current Accounts Payable is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Accounts Payable of $0.02 Mil. The current Accounts Payable is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Dakshidin (DKSC), the current Accounts Payable is $0.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.